About us

Innovating MedTech

The UCL Institute of Biomedical Engineering (IBME) has high ambitions – no less than to be one of the world’s best university-based proponents of medical technologies R&D, and of its successful translation into products of significant patient benefit and real commercial value. In a 2011 survey commissioned by the NIHR, UCL Biomedical Engineering led the UK in the percentage share of most highly cited publications, at 13%.

IBME is a bridge between six biomedical, engineering, life and physical science faculties, and the hospitals, in the UCL estate. It aims to establish a cross-faculty consortium for the promotion of innovation and translational research in medical technologies viz. non-pharmaceutical products that are used to diagnose, monitor and treat diseases or conditions that affect humans.

Alongside a goal of supporting translational activities, including direct support of PIs via site miners, transaction experts and venture facilitators, will be bottom-up support of postgraduates through an Enterprise Academy and taught courses on MedTech Entrepreneurship.


Cookies on IBME website

Our website uses cookies to provide us with important information about visitors. By continuing to browse the site we'll assume that you are happy to receive all cookies set by IBME.